Nanox Secures Costa Rica Distribution Deal for Nanox.ARC
Event summary
- Nanox Imaging Ltd. signed a distribution agreement with SOLME RC, S.A. to market and support the Nanox.ARC in Costa Rica.
- SOLME is a registered supplier for Costa Rica’s principal healthcare provider, the Caja Costarricense de Seguro Social (CCSS).
- Costa Rica marks Nanox’s third Latin American market entry in 2026, following Argentina and Peru.
- The agreement includes marketing, distribution, installation, training, and ongoing technical support for Nanox.ARC.
- Commercialization in Costa Rica will follow a six-month POC device registration period before full regulatory approval.
The big picture
Nanox’s deal with SOLME RC, S.A. strengthens its foothold in Latin America, targeting markets with strong public healthcare systems. The partnership aligns with Nanox’s strategy of collaborating with local distributors to expand access to medical imaging. Success in Costa Rica could serve as a blueprint for further regional growth, particularly in countries with centralized healthcare purchasers.
What we're watching
- Regulatory Timelines
- The pace at which Nanox.ARC secures full regulatory approval in Costa Rica will determine commercialization speed.
- Market Penetration
- Whether Nanox can leverage SOLME’s existing relationships to gain traction within Costa Rica’s public healthcare system.
- Strategic Expansion
- How Nanox’s Latin American strategy evolves beyond Argentina, Peru, and Costa Rica.